DMAA · Drugs Made In America Acquisition Corp.
$10.75
+0.03 (+0.23%)
At close · Aug 21
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Additionally, the date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company's ability to continue as a going concern. These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. Management plans to address this uncertainty through a Business Combination. There is no assurance that the Company's plans to raise capital or to consummate a Business Combination will be successful within the Combination Period.”View the 10-Q filed Aug 14, 2026
Market Cap
$260.98M
Shares
24.28M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding DMAA
3 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| First Trust Merger Arbitrage Fund | — | 1,929,288 | $20,257,524 | 1.28% | Long | 2026-03-31 | |
| First Trust Multi-Strategy Fund | — | 299,907 | $3,149,024 | 0.24% | Long | 2026-03-31 | |
| RiverNorth Opportunities Fund Inc. | RIV | 100,000 | $1,050,000 | 0.32% | Long | 2026-03-31 |
Showing 1–3 of 3 positions
Key facts
CIK
2028614
CUSIP
G2847J104
13F (30d)
46 filings
43 filers